Upstream Bio, Inc. (UPB)
Upstream Bio Market Cap : 87.15M for Nov. 20, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2026 | 87.15M |
| November 19, 2026 | 109.62M |
| November 18, 2026 | 114.01M |
| November 17, 2026 | 115.10M |
| November 16, 2026 | 117.84M |
| November 13, 2026 | 152.38M |
| November 12, 2026 | 156.76M |
| November 11, 2026 | 175.40M |
| November 10, 2026 | 185.26M |
| November 09, 2026 | 196.22M |
| November 06, 2026 | 177.04M |
| November 05, 2026 | 175.94M |
| November 04, 2026 | 202.65M |
| November 03, 2026 | 185.67M |
| November 02, 2026 | 183.48M |
| October 30, 2026 | 186.77M |
| October 29, 2026 | 179.10M |
| October 28, 2026 | 163.22M |
| October 27, 2026 | 152.81M |
| October 26, 2026 | 150.62M |
| October 23, 2026 | 150.07M |
| October 22, 2026 | 163.77M |
| October 21, 2026 | 153.36M |
| October 20, 2026 | 154.45M |
| October 19, 2026 | 153.36M |
| Date | Value |
|---|---|
| October 16, 2026 | 151.17M |
| October 15, 2026 | 184.58M |
| October 14, 2026 | 187.32M |
| October 13, 2026 | 194.44M |
| October 12, 2026 | 228.40M |
| October 09, 2026 | 257.42M |
| October 08, 2026 | 249.21M |
| October 07, 2026 | 252.49M |
| October 06, 2026 | 251.40M |
| October 05, 2026 | 265.64M |
| October 02, 2026 | 276.05M |
| October 01, 2026 | 276.05M |
| September 30, 2026 | 288.64M |
| September 29, 2026 | 284.26M |
| September 28, 2026 | 290.29M |
| September 25, 2026 | 293.57M |
| September 24, 2026 | 283.17M |
| September 23, 2026 | 284.26M |
| September 22, 2026 | 300.69M |
| September 21, 2026 | 293.85M |
| September 18, 2026 | 292.48M |
| September 17, 2026 | 290.83M |
| September 16, 2026 | 291.93M |
| September 15, 2026 | 300.15M |
| September 14, 2026 | 318.22M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.956B |
| Alnylam Pharmaceuticals, Inc. | 19.25B |
| Anika Therapeutics, Inc. | 177.20M |
| Savara, Inc. | 875.58M |
| Arrowhead Pharmaceuticals, Inc. | 5.845B |
Market Cap Related Metrics
| PS Ratio | 30.18 |
| PEG Ratio | -0.0166 |
| Price to Book Value | 0.3725 |
| Price | 1.59 |
| Earnings Yield | -189.5% |
| PEGY Ratio | -0.0166 |